Skip to main content
. 2017 Aug 25;21(2):175–186. doi: 10.1093/ijnp/pyx080

Figure 1.

Figure 1.

Schematic timeline of drug administration and behavioral testing. (A) Experimental procedure for the various scopolamine dose groups and cognitive and depression-like behaviors in the mice. (B) Experimental procedure for the assessment of the effects of L-type voltage-dependent calcium channel (L-VDCC) blocker verapamil in the regulation of behavioral changes and brain derived neurotrophic factor (BDNF) and VGF levels produced by various doses of scopolamine.